Login / Signup

Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies.

Vivek Y ReddyYue ZhongAlysha M McGovernStacey L AmorosiMeghan B GavaghanDeanna S HertzKaywei LowScott FreemanDavid R Holmes
Published in: ClinicoEconomics and outcomes research : CEOR (2024)
LAAC yielded the lowest overall and patient costs. Warfarin costs were largely driven by clinical events, which may represent an unplanned financial burden for patients. These considerations should be incorporated into shared decision-making discussions about stroke prophylaxis strategies.
Keyphrases